Safety and immunogenicity of meningococcal (Groups A and C) polysaccharide vaccine in children 2 to 6 y of age in China: a randomized, active-controlled, non-inferiority study

Meningococcal serogroups A and C cause significant numbers of cases in China. The Sanofi Pasteur meningococcal polysaccharide A + C vaccine (Men-AC) was licensed in China in 1995. Immunogenicity and safety of a single dose of Men-AC against a similar marketed vaccine, the Lanzhou Institute serogroup...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Feng-Cai, Hu, Yue-Mei, Li, Ya-Nan, Shu, Jean-Denis, Oster, Philipp
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993220/
https://www.ncbi.nlm.nih.gov/pubmed/33270487
http://dx.doi.org/10.1080/21645515.2020.1801077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993220/
https://www.ncbi.nlm.nih.gov/pubmed/33270487
http://dx.doi.org/10.1080/21645515.2020.1801077

Ejemplares similares